Treatment Burden in People with Hypertension is Correlated with Patient Experience with Self-Management

References

1. 1.↵
   1. Khera R,
   2. Lu Y,
   3. Lu J,
   4. et al

   . Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. BMJ 2018;362:k2357.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Lorig KR,
   2. Holman HR

   . Self-management education: History, definition, outcomes, and mechanisms. Ann Behav Med 2003;26:1–7.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Eton DT,
   2. Yost KJ,
   3. Lai J,
   4. et al

   . Development and validation of the Patient Experience with Treatment and Self-management (PETS): a patient-reported measure of treatment burden. Qual Life Res 2017;26:489–503.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Schreiner N,
   2. DiGennaro S,
   3. Harwell C,
   4. Burant C,
   5. Daly B,
   6. Douglas S

   . Treatment burden as a predictor of self-management adherence within the primary care population. Appl Nurs Res 2020;54:151301.

   OpenUrl
5. 5.↵
   1. Osborn CY,
   2. Kripalani S,
   3. Goggins KM,
   4. Wallston KA

   . Financial strain is associated with medication nonadherence and worse self-rated health among cardiovascular patients. J Health Care Poor Underserved 2017;28:499–513.

   OpenUrl